透景生命股票讨论区

The marked drop in Tellgen's revenue and EPS estimates signals falling analyst sentiment, suggesting potential hurdles in the future. With the industry's 20% annual revenue growth, Tellgen's projected 15% rate is slower, stirring market concerns.